DE3062609D1 - Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds - Google Patents

Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds

Info

Publication number
DE3062609D1
DE3062609D1 DE8080103461T DE3062609T DE3062609D1 DE 3062609 D1 DE3062609 D1 DE 3062609D1 DE 8080103461 T DE8080103461 T DE 8080103461T DE 3062609 T DE3062609 T DE 3062609T DE 3062609 D1 DE3062609 D1 DE 3062609D1
Authority
DE
Germany
Prior art keywords
compounds
group
carbon atoms
preparing
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080103461T
Other languages
German (de)
English (en)
Inventor
Tetsuo Shiba
Yuichi Yamamura
Osamu Nagase
Shozo Kotani
Hidemasa Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3062609D1 publication Critical patent/DE3062609D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8080103461T 1979-06-21 1980-06-20 Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds Expired DE3062609D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7831779A JPS5618996A (en) 1979-06-21 1979-06-21 Muramyldipeptide derivative

Publications (1)

Publication Number Publication Date
DE3062609D1 true DE3062609D1 (en) 1983-05-11

Family

ID=13658554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080103461T Expired DE3062609D1 (en) 1979-06-21 1980-06-20 Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds

Country Status (11)

Country Link
US (1) US4317771A (US20100223739A1-20100909-C00025.png)
EP (1) EP0021367B1 (US20100223739A1-20100909-C00025.png)
JP (1) JPS5618996A (US20100223739A1-20100909-C00025.png)
AT (1) ATE2958T1 (US20100223739A1-20100909-C00025.png)
AU (1) AU534233B2 (US20100223739A1-20100909-C00025.png)
CA (1) CA1183128A (US20100223739A1-20100909-C00025.png)
DE (1) DE3062609D1 (US20100223739A1-20100909-C00025.png)
ES (1) ES492664A0 (US20100223739A1-20100909-C00025.png)
PH (1) PH15892A (US20100223739A1-20100909-C00025.png)
SU (1) SU1190990A3 (US20100223739A1-20100909-C00025.png)
ZA (1) ZA803483B (US20100223739A1-20100909-C00025.png)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482959A2 (fr) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
GR78246B (US20100223739A1-20100909-C00025.png) * 1981-01-23 1984-09-26 Ciba Geigy Ag
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
JPS59172497A (ja) * 1983-03-22 1984-09-29 Dai Ichi Seiyaku Co Ltd 新規ムラミルペプチド誘導体
FR2546756B1 (fr) * 1983-06-03 1985-11-29 Centre Nat Rech Scient Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
US4474693A (en) * 1983-10-31 1984-10-02 E. R. Squibb & Sons, Inc. ACE inhibitors produced from Nocardia orientalis
JPS6157597A (ja) * 1984-08-29 1986-03-24 Toshiyuki Hamaoka ムラミルペプチド活性エステル誘導体
JPS6393724A (ja) * 1986-10-09 1988-04-25 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体含有鎮痛消炎剤
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
CN100522995C (zh) * 2003-10-22 2009-08-05 中国医学科学院药物研究所 胞壁酰-丙氨酰-d-异谷氨酰胺衍生物、制法和其药物组合物与用途
US9688718B2 (en) 2008-01-11 2017-06-27 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising hydrogenases and related products, methods and systems
US8883729B2 (en) * 2008-05-22 2014-11-11 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
US10151037B2 (en) 2009-01-12 2018-12-11 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide dependent target reduction, and related methods and systems
CN103204901B (zh) 2010-05-27 2016-03-09 中国医学科学院药物研究所 紫杉醇共缀物的制备方法
CN102219834A (zh) * 2011-04-14 2011-10-19 北京市丰硕维康技术开发有限责任公司 一种制备罗莫肽的方法
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2017044899A1 (en) 2015-09-11 2017-03-16 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems
KR20230171435A (ko) 2021-03-19 2023-12-20 트레인드 테라퓨틱스 디스커버리, 아이엔씨. 훈련된 면역을 조절하기 위한 화합물 및 이의 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
FR2358159A1 (fr) * 1976-07-16 1978-02-10 Anvar Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation

Also Published As

Publication number Publication date
CA1183128A (en) 1985-02-26
EP0021367B1 (en) 1983-04-06
PH15892A (en) 1983-04-14
JPS5618996A (en) 1981-02-23
US4317771A (en) 1982-03-02
JPS6227079B2 (US20100223739A1-20100909-C00025.png) 1987-06-12
AU534233B2 (en) 1984-01-12
ES8200645A1 (es) 1981-11-16
ES492664A0 (es) 1981-11-16
ZA803483B (en) 1981-06-24
SU1190990A3 (ru) 1985-11-07
ATE2958T1 (de) 1983-04-15
EP0021367A1 (en) 1981-01-07
AU5910180A (en) 1981-01-08

Similar Documents

Publication Publication Date Title
DE3062609D1 (en) Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds
AU515774B2 (en) Benzopyran derivatives
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
KR870000354A (ko) N-(2-아미노 아실아미도-2-데옥시-헥소실)-아미드, -카르바메이트 및 -우레아의 제조방법
AU3926295A (en) Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
SE8004792L (sv) Nya tetra- eller pentapeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
DE3270583D1 (en) Inhibitors of mammalian collagenase
IE801251L (en) Inhibitors of mammalian collagenase
GR78771B (US20100223739A1-20100909-C00025.png)
ES2076623T3 (es) 3,4-dihidro-naftalinas sustituidas, su procedimiento de preparacion y medicamentos que las contienen.
RS50423B (sr) Novi derivati oktahidro-6,10-diokso-6h-piridazino(1,2-a) (1,2) diazepin-1-karboksilne kiseline, njihov postupak dobijanja i njihova primena za dobijanje farmaceutski aktivnih jedinjenja
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
KR950702566A (ko) 사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
GEP19970937B (en) Method of producing derivatives of muramyldipeptide
EP0331756A4 (en) Agents for prophylaxis and treatment of thrombopenia
NL7505473A (nl) Werkwijze voor het bereiden van pyroglutamylver- bindingen met antidepressieve werking.
ES465567A1 (es) Procedimiento para la preparacion de disulfuro de 2-amino- ciclopent-1-en-1tiocarbonilo
ES8204413A1 (es) Un procedimiento para la produccion de una amida dipeptidicade un l-aspartil-d-aminoacido